Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LovedBy is a UK-based digital health company that specializes in behavioral science and artificial intelligence to improve the management of chronic conditions. The company's core platform, Nudg, is a digital therapeutic designed to support young people living with Type 1 Diabetes by providing personalized, data-driven interventions. By utilizing real-time data from continuous glucose monitors and other wearables, the platform delivers proactive "nudges" to encourage healthy habits and treatment adherence. LovedBy aims to bridge the gap between clinical data and daily patient behavior, reducing the mental burden of disease management. Their technology is built on a foundation of behavioral economics to ensure that health interventions are both timely and effective. The company collaborates with healthcare providers and insurers to integrate their digital solutions into standard care pathways.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LovedBy.